Lu, Ying-Mei <br/><br/>
DY-9760e inhibits endothelin-1-induced cardiomyocyte hypertrophy through inhibition of CaMKII and ERK activities.  [electronic resource] 

 -  Cardiovascular therapeutics  2009 
 - 17-27 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1755-5914 
<br/><br/><label>Standard No.: </label>10.1111/j.1755-5922.2008.00068.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Animals, Newborn<br/>Atrial Natriuretic Factor--metabolism<br/>Benzylamines--pharmacology<br/>Butadienes--pharmacology<br/>Calcimycin--pharmacology<br/>Calcium Signaling--drug effects<br/>Calcium-Calmodulin-Dependent Protein Kinase Type 2--antagonists & inhibitors<br/>Cardiomegaly--enzymology<br/>Cell Proliferation--drug effects<br/>Cell Size--drug effects<br/>Cells, Cultured<br/>DNA Replication--drug effects<br/>Endothelin-1--metabolism<br/>Extracellular Signal-Regulated MAP Kinases--antagonists & inhibitors<br/>Indazoles--pharmacology<br/>Ionophores--pharmacology<br/>Myocytes, Cardiac--drug effects<br/>Natriuretic Peptide, Brain--metabolism<br/>Nitriles--pharmacology<br/>Phosphorylation<br/>Protein Kinase Inhibitors--pharmacology<br/>RNA, Messenger--metabolism<br/>Rats<br/>Rats, Wistar<br/>Sulfonamides--pharmacology<br/>Time Factors<br/>Transfection